2026年春季,在加拿大专利到期后,一般的二甲基硫酸盐可能会将药品价格降低65%。 Generic semaglutide may cut drug prices by 65% in Canada by spring 2026 after patent expiry.

在Ozempic和Wegovy等药物中使用的混血素的通用版本,早在2026年春天,即Novo Nordisk专利于2026年1月4日到期后,加拿大的价格可能降低65%以上。 Generic versions of semaglutide, used in drugs like Ozempic and Wegovy, could lower prices by over 65% in Canada as early as spring 2026, following the expiration of Novo Nordisk’s patent on January 4. 加拿大卫生部正在审查九种通用配方,可在180天内获得批准。 Health Canada is reviewing nine generic formulations, with approvals possible within 180 days. 这一行动可以大大改善费用高昂的病人获得治疗的机会。 The move could greatly improve access for patients struggling with high costs. 虽然对糖尿病和体重管理有效,但该药物在大约一半的使用者中可造成恶心、呕吐和腹泻,在停止治疗后通常会恢复体重。 While effective for diabetes and weight management, the drug can cause nausea, vomiting, and diarrhea in about half of users, and weight regain often occurs after stopping. 专家敦促病人在使用前先咨询保健服务提供者,特别是在人们日益关切过量开药的情况下。 Experts urge patients to consult healthcare providers before use, especially amid rising concerns about overprescription.